Logo image of XSPA

XPRESSPA GROUP INC (XSPA) Stock Fundamental Analysis

USA - NASDAQ:XSPA - US98420U7037 - Common Stock

0.655 USD
-0.04 (-5.65%)
Last: 10/24/2022, 8:00:02 PM
0.6501 USD
0 (-0.75%)
After Hours: 10/24/2022, 8:00:02 PM
Fundamental Rating

3

XSPA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 75 industry peers in the Diversified Consumer Services industry. The financial health of XSPA is average, but there are quite some concerns on its profitability. XSPA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

XSPA had negative earnings in the past year.
XSPA had a positive operating cash flow in the past year.
XSPA Yearly Net Income VS EBIT VS OCF VS FCFXSPA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -20M -40M -60M -80M

1.2 Ratios

Industry RankSector Rank
ROA -3.28%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XSPA Yearly ROA, ROE, ROICXSPA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 200 -200 -400

1.3 Margins

Industry RankSector Rank
OM -0.24%
PM (TTM) -3.55%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XSPA Yearly Profit, Operating, Gross MarginsXSPA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -200 -400 -600 -800 -1K

More info and screens

5

2. Health

2.1 Basic Checks

XSPA does not have a ROIC to compare to the WACC, probably because it is not profitable.
XSPA has more shares outstanding than it did 1 year ago.
XSPA has a better debt/assets ratio than last year.
XSPA Yearly Shares OutstandingXSPA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
XSPA Yearly Total Debt VS Total AssetsXSPA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -2.74, we must say that XSPA is in the distress zone and has some risk of bankruptcy.
There is no outstanding debt for XSPA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.74
ROIC/WACCN/A
WACC8.27%
XSPA Yearly LT Debt VS Equity VS FCFXSPA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M 40M 60M 80M

2.3 Liquidity

XSPA has a Current Ratio of 5.93. This indicates that XSPA is financially healthy and has no problem in meeting its short term obligations.
XSPA has a Quick Ratio of 5.84. This indicates that XSPA is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 5.93
Quick Ratio 5.84
XSPA Yearly Current Assets VS Current LiabilitesXSPA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.67% over the past year.
The Revenue has grown by 417.44% in the past year. This is a very strong growth!
XSPA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.80% yearly.
EPS 1Y (TTM)88.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)417.44%
Revenue growth 3Y13.75%
Revenue growth 5Y43.8%
Sales Q2Q%49.55%

3.2 Future

The Earnings Per Share is expected to grow by 10.45% on average over the next years. This is quite good.
Based on estimates for the next years, XSPA will show a small growth in Revenue. The Revenue will grow by 0.23% on average per year.
EPS Next Y-814%
EPS Next 2Y-172.76%
EPS Next 3Y-11.28%
EPS Next 5Y10.45%
Revenue Next Year-2.07%
Revenue Next 2Y0.7%
Revenue Next 3Y0.05%
Revenue Next 5Y0.23%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XSPA Yearly Revenue VS EstimatesXSPA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
XSPA Yearly EPS VS EstimatesXSPA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2017 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200 -250

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

XSPA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year XSPA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XSPA Price Earnings VS Forward Price EarningsXSPA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.35
XSPA Per share dataXSPA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

A cheap valuation may be justified as XSPA's earnings are expected to decrease with -11.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-172.76%
EPS Next 3Y-11.28%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XSPA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XPRESSPA GROUP INC

NASDAQ:XSPA (10/24/2022, 8:00:02 PM)

After market: 0.6501 0 (-0.75%)

0.655

-0.04 (-5.65%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)08-15 2022-08-15/amc
Earnings (Next)11-14 2022-11-14/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners1.84%
Ins Owner Change0%
Market Cap61.58M
Analysts82.86
Price Target2.04 (211.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.1%
Min EPS beat(2)21.57%
Max EPS beat(2)34.64%
EPS beat(4)3
Avg EPS beat(4)56.94%
Min EPS beat(4)-50.98%
Max EPS beat(4)222.55%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)10.34%
Min Revenue beat(2)-0.7%
Max Revenue beat(2)21.38%
Revenue beat(4)3
Avg Revenue beat(4)47.5%
Min Revenue beat(4)-0.7%
Max Revenue beat(4)163.26%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.66
P/FCF N/A
P/OCF 7.94
P/B 0.86
P/tB 0.99
EV/EBITDA -2.35
EPS(TTM)-0.04
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.08
OCFY12.6%
SpS1
BVpS0.76
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.28%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -0.24%
PM (TTM) -3.55%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 330.54%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.93
Quick Ratio 5.84
Altman-Z -2.74
F-Score8
WACC8.27%
ROIC/WACCN/A
Cap/Depr(3y)119.29%
Cap/Depr(5y)89.95%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-814%
EPS Next 2Y-172.76%
EPS Next 3Y-11.28%
EPS Next 5Y10.45%
Revenue 1Y (TTM)417.44%
Revenue growth 3Y13.75%
Revenue growth 5Y43.8%
Sales Q2Q%49.55%
Revenue Next Year-2.07%
Revenue Next 2Y0.7%
Revenue Next 3Y0.05%
Revenue Next 5Y0.23%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y164.29%
OCF growth 3YN/A
OCF growth 5YN/A